Denmark-based, Tetra Pharm Technologies (TPT) is a biotech startup committed to treat neuropathic pain & mental health disorders, by “designing & developing new drug formulations/ candidates, conducting clinicals & commercializing medicines targeting the endocannabinoid system (ECS)”. <Quick primer on the ECS: it regulates & controls many critical body functions such as, via CB1 receptors (found mostly in the brain) - learning & memory, emotional processing, sleep, temperature control, pain control, & via CB2 receptors (found mostly in tissue) - inflammatory & immune responses >. Worth keeping mind, the European market for cannabinoid-based treatment is expected to reach €3.2b by 2025. TPT is said to have closed “several significant distribution deals” across main European markets &...

Founded in 2017 by Daniel Stofan (CEO) & Lukas Hruby (CTO), UK & Czech Republic-based GoodVision helps modern cities respond to traffic challenges. The startups main product, “GoodVision Video Insights”, is a SaaS "traffic analytics" platform, which automates traffic data collection (from existing camera infrastructure) for traffic (model) calibration. Using the platform can save traffic modelers up to 95% of time. According to the founders, “in the past, traffic data was collected manually by humans on the road or single-purpose sensors, & transport analytics was done with pen & paper. GoodVision is the place where all related parties can work together on their projects & have most of their work tasks automated”. GoodVision already claim...